JDRF "Walk For The Cure" Nov 1st @ Tempe Town Lake, Tempe,AZ


   

Mark Pareja is walking with Go Daddy on November 1, 2008 in Tempe, AZ.

Mark Pareja's Image

Greetings Everyone!

As you may not be aware, GoDaddy is a large sponsor of the JDRF Walk for the Cure this year I will be walking and I'm asking all of our friends, family, and business partners to participate in the walk. However if busy work and personal schedules conflict I'm asking for a sponsorship donation, any amount helps.

P.s. I'm willing to wear stickers, logos, headbands, face paint, pins, hats, and even temporary tattoos. . .


Our goal: To raise $105 million to help fund research for a cure for type 1 diabetes and its complications.

Type 1, or juvenile, diabetes, is a devastating, often deadly disease that affects millions of people--a large and growing percentage of them children.

Many people think type 1 diabetes can be controlled by insulin. While insulin does keep people with type 1 diabetes alive, it is NOT a cure. Aside from the daily challenges of living with type 1 diabetes, there are many severe, often fatal, complications caused by the disease.

That's the bad news... and yes, it's pretty bad.

The good news, though, is that a cure for type 1 diabetes is within reach. In fact, JDRF funding and leadership is associated with most major scientific breakthroughs in type 1 diabetes research to date. And JDRF funds a major portion of all type 1 diabetes research worldwide, more than any other charity.

I'm writing to ask for your support because now more than ever, EACH of us can be a part of bringing about a cure. Each of us can make a real difference

Won't you please give to JDRF as generously as you're able?

Together, we can make the cure a reality.

Thank you,

Mark Pareja





Help JDRF—and me—find a cure for diabetes:
     Donate Now
     E-mail This Page to a Friend

If this page contains inappropriate material, click here to report the issue to JDRF.

 

What did you think of this article?




Trackbacks
  • No trackbacks exist for this entry.
Comments
  • No comments exist for this entry.
Leave a comment

Submitted comments will be subject to moderation before being displayed.

 Enter the above security code (required)

 Name

 Email (will not be published)

 Website

Your comment is 0 characters limited to 3000 characters.